HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
CDNA
Caredx Inc
Healthcare Diagnostics & Research · California, USA · Reports in usd
Market Cap: $1.13B
Market Cap
$1.13B
Enterprise Val
$968.8M
P/E Ratio
-52.77
P/B Ratio
3.72
Trailing PEG (1Y)
0.50
As Of
Apr 27, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$303.1M
Gross Margin67.24%
Profit Margin67.24%
Return on Equity-6.47%
Return on Assets-4.80%
Current Ratio2.86
Debt/Equity0.06
LT Debt/Equity0.06
Revenue Per Share2.11

Income Statement

Dec 31, 2025
Revenue$108.4M
Cost of Revenue$35.5M
Gross Profit$72.9M
R&D$19.3M
SG&A$59.6M
Operating Expenses$78.9M
Operating Income-$6.0M
Interest Expense-$2.0M
Tax Expense$345.0K
Net Income-$4.1M
EPS (Basic)$-0.08
EPS (Diluted)$-0.08
EBIT-$5.8M
EBITDA-$516.0K
Consolidated Income-$4.1M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$66.0M
Accounts Receivable$42.6M
Inventory$26.7M
Current Assets$257.1M
LT Investments$24.2M
Property, Plant & Equipment$55.7M
Intangibles$72.3M
Non-Current Assets$156.1M
Total Assets$413.2M
Accounts Payable$10.0M
Current Debt$0.00
Current Liabilities$89.8M
LT Debt$19.7M
Non-Current Liabilities$20.3M
Total Liabilities$110.1M
Total Debt$19.7M
Retained Earnings-$735.4M
Shareholder Equity$303.1M
Shares Outstanding51,432,639

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$21.4M
Investing Cash Flow-$34.9M
Financing Cash Flow-$12.5M
CapEx-$2.0M
Free Cash Flow$19.4M
Depreciation & Amort.$5.3M
Stock-Based Comp$8.1M
Acquisitions / Disposals$0.00
Investment Activity-$32.9M
Debt Issued/Repaid$0.00
Equity Issued/Repaid-$10.8M
Dividends Paid$0.00
Net Change in Cash-$26.0M
Data cached · Meta live · Daily live · Statements live · TTL 24h